Skip to main content

1 Result(s)

within J. Poggi-Bach Remove this filter

and

  1. No Access

    Article

    NTBC treatment in tyrosinaemia type I: Long-term outcome in French patients

    We describe a retrospective study of long-term outcome of 46 patients treated and regularly followed in France with 2-(2-nitro-4-trifluoromethylbenzoyl)-1, 3-cyclohexanedione (NTBC) for tyrosinaemia type I. Mo...

    A. Masurel-Paulet, J. Poggi-Bach, M.-O. Rolland… in Journal of Inherited Metabolic Disease (2008)